SPNS2 Loss Exposes a MAPK Sensitive AML State
A peer-reviewed Nature Communications article published online 28 October links SPNS2 loss to altered sphingomyelin-rich membrane nanodomains, RAS localization and MAPK signaling in AML. Patient expression associations and mouse MEK-inhibitor sensitization suggest a context-specific…
